Ipamorelin Peptide

What is Ipamorelin?

A pentapeptide composed of five amino acids, serving as a growth hormone (GH) secretagogue and agonist. It uniquely stimulates the pituitary gland to enhance the secretion of growth hormone.

Key Properties:

• Stimulates Growth Hormone Release: Encourages the pituitary gland to increase growth hormone release.
• Inhibits Somatostatin Production: Reduces levels of somatostatin, which can negatively affect growth hormone output.
• Boosts IGF-1 Production: Increases Insulin-like Growth Factor 1, essential for muscle and skeletal repair.
• Selective Action: Targets growth hormone release without significantly affecting cortisol or prolactin levels.
• Enhances Recovery and Performance: Supports faster recovery and improves physical performance through increased growth hormone levels.
• Synergistic Effects with CJC-1295: When paired with CJC-1295, it exhibits enhanced efficacy, leading to more significant results in GH release without increasing side effects.

Research Use:

Ipamorelin is a focus for growth hormone therapy research, offering potential for muscle and bone growth, repair, and metabolic health improvement with a safer profile for long-term use. It has synergistic benefits when combined with CJC-1295 (with DAC).

Detailed Description

Ipamorelin is a pentapeptide, meaning its structure comprises five amino acids. It is a GH secretagogue and an agonist, meaning it can bind specific cell receptors and provoke a cellular response. Ipamorelin’s operational mechanics enable the peptide to stimulate the production of pituitary gland-based expression of secretions related to growth amongst animal test subjects. At the same time, the presence of the peptide has been shown to inhibit the production of a secretion known as somatostatin. Additionally, it has been determined that Ipamorelin Peptide can boost the production of IGF-1, or Insulin-like Growth Factor 1. Its presence plays a vital role in the overall growth and repair of muscular and skeletal tissue